212 related articles for article (PubMed ID: 31705439)
21. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
22. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF
Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221
[TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
[TBL] [Abstract][Full Text] [Related]
25. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Job S; Draskovic I; Burnichon N; Buffet A; Cros J; Lépine C; Venisse A; Robidel E; Verkarre V; Meatchi T; Sibony M; Amar L; Bertherat J; de Reyniès A; Londoño-Vallejo A; Favier J; Castro-Vega LJ; Gimenez-Roqueplo AP
Clin Cancer Res; 2019 Jan; 25(2):760-770. PubMed ID: 30301828
[TBL] [Abstract][Full Text] [Related]
26. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.
Papathomas TG; de Krijger RR; Tischler AS
Semin Diagn Pathol; 2013 Aug; 30(3):207-23. PubMed ID: 24144290
[TBL] [Abstract][Full Text] [Related]
27. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of Succinate dehydrogenase B (SDHB) immunohistochemistry in guiding mutational screening among patients with pheochromocytoma-paraganglioma syndromes.
Pai R; Manipadam MT; Singh P; Ebenazer A; Samuel P; Rajaratnam S
APMIS; 2014 Nov; 122(11):1130-5. PubMed ID: 24735130
[TBL] [Abstract][Full Text] [Related]
29. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
Loriot C; Burnichon N; Gadessaud N; Vescovo L; Amar L; Libé R; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2012 Jun; 97(6):E954-62. PubMed ID: 22492777
[TBL] [Abstract][Full Text] [Related]
30. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
[TBL] [Abstract][Full Text] [Related]
31. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
33. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
Fishbein L; Khare S; Wubbenhorst B; DeSloover D; D'Andrea K; Merrill S; Cho NW; Greenberg RA; Else T; Montone K; LiVolsi V; Fraker D; Daber R; Cohen DL; Nathanson KL
Nat Commun; 2015 Jan; 6():6140. PubMed ID: 25608029
[TBL] [Abstract][Full Text] [Related]
34. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
[TBL] [Abstract][Full Text] [Related]
35. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract][Full Text] [Related]
36. Models of parent-of-origin tumorigenesis in hereditary paraganglioma.
Hoekstra AS; Devilee P; Bayley JP
Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
38. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.
Vanharanta S; Buchta M; McWhinney SR; Virta SK; Peçzkowska M; Morrison CD; Lehtonen R; Januszewicz A; Järvinen H; Juhola M; Mecklin JP; Pukkala E; Herva R; Kiuru M; Nupponen NN; Aaltonen LA; Neumann HP; Eng C
Am J Hum Genet; 2004 Jan; 74(1):153-9. PubMed ID: 14685938
[TBL] [Abstract][Full Text] [Related]
39. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
40. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]